Park DJ - Search Results

1

A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ. Park DJ, et al. Cancer Res. 2001 Dec 15;61(24):8654-8. Cancer Res. 2001. PMID: 11751380

2

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer.

Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei D, Groshen S, Lenz HJ. Park DJ, et al. Int J Colorectal Dis. 2002 Jan;17(1):46-9. doi: 10.1007/s003840100358. Int J Colorectal Dis. 2002. PMID: 12018454

3

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.

Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, Lenz HJ. Stoehlmacher J, et al. Among authors: park dj. J Natl Cancer Inst. 2002 Jun 19;94(12):936-42. doi: 10.1093/jnci/94.12.936. J Natl Cancer Inst. 2002. PMID: 12072547

4

Tailoring chemotherapy in advanced colorectal cancer.

Park DJ, Stoehlmacher J, Lenz HJ. Park DJ, et al. Curr Opin Pharmacol. 2003 Aug;3(4):378-85. doi: 10.1016/s1471-4892(03)00082-1. Curr Opin Pharmacol. 2003. PMID: 12901946 Review.

5

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.

Zhang W, Park DJ, Lu B, Yang DY, Gordon M, Groshen S, Yun J, Press OA, Vallböhmer D, Rhodes K, Lenz HJ. Zhang W, et al. Among authors: park dj. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):600-5. Clin Cancer Res. 2005. PMID: 15701846

6

Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.

Zhang W, Stoehlmacher J, Park DJ, Yang D, Borchard E, Gil J, Tsao-Wei DD, Yun J, Gordon M, Press OA, Rhodes K, Groshen S, Lenz HJ. Zhang W, et al. Among authors: park dj. Clin Colorectal Cancer. 2005 Jul;5(2):124-31. doi: 10.3816/ccc.2005.n.025. Clin Colorectal Cancer. 2005. PMID: 16098254

7

ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.

Park DJ, Zhang W, Stoehlmacher J, Tsao-Wei D, Groshen S, Gil J, Yun J, Sones E, Mallik N, Lenz HJ. Park DJ, et al. Clin Adv Hematol Oncol. 2003 Mar;1(3):162-6. Clin Adv Hematol Oncol. 2003. PMID: 16224397

8

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.

Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, Lenz HJ. Stoehlmacher J, et al. Among authors: park dj. Br J Cancer. 2004 Jul 19;91(2):344-54. doi: 10.1038/sj.bjc.6601975. Br J Cancer. 2004. PMID: 15213713 Free PMC article.

9

A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer.

Stoehlmacher J, Ghaderi V, Iobal S, Groshen S, Tsao-Wei D, Park D, Lenz HJ. Stoehlmacher J, et al. Anticancer Res. 2001 Jul-Aug;21(4B):3075-9. Anticancer Res. 2001. PMID: 11712813

10

Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.

Zhang W, Gordon M, Press OA, Rhodes K, Vallböhmer D, Yang DY, Park D, Fazzone W, Schultheis A, Sherrod AE, Iqbal S, Groshen S, Lenz HJ. Zhang W, et al. Pharmacogenet Genomics. 2006 Jul;16(7):475-83. doi: 10.1097/01.fpc.0000220562.67595.a5. Pharmacogenet Genomics. 2006. PMID: 16788380 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,332 results

Search Page

Filters